Hypermethylated ZNF582 and PAX1 genes in oral scrapings collected from cancer-adjacent normal oral mucosal sites are associated with aggressive progression and poor prognosis of oral cancer-Reference-Cited by-同舟云学术

Hypermethylated ZNF582 and PAX1 genes in oral scrapings collected from cancer-adjacent normal oral mucosal sites are associated with aggressive progression and poor prognosis of oral cancer

Published:2017-12 Issue: Volume:75 Page:169-177
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Cheng Shih-Jung,Chang Chi-Feng,Ko Hui-Hsin^ORCID,Liu Yi-Ching,Peng Hsin-Hui,Wang Huei-Jen,Lin Hsiao-Shan,Chiang Chun-Pin

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference38 articles.

1. Global epidemiology of oral and oropharyngeal cancer;Warnakulasuriya;Oral Oncol,2009

2. Factors influencing the incidence and prognosis of second primary tumors in patients with oral squamous cell carcinoma;Ko;Head Neck,2016

3. Epigenetics: a landscape takes shape;Goldberg;Cell,2007

4. Key tumor suppressor genes inactivated by “greater promoter” methylation and somatic mutations in head and neck cancer;Guerrero-Preston;Epigenetics,2014

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Universal penalized regression (Elastic-net) model with differentially methylated promoters for oral cancer prediction;European Journal of Medical Research;2024-09-11

2. Promoter DNA methylation patterns in oral, laryngeal and oropharyngeal anatomical regions are associated with tumor differentiation, nodal involvement and survival;Oncology Letters;2024-01-08

3. Utilization of PAX1 methylation test for cervical cancer screening of non-HPV16/18 high-risk HPV infection in women;Future Oncology;2023-09

4. ZNF582 overexpression restrains the progression of clear cell renal cell carcinoma by enhancing the binding of TJP2 and ERK2 and inhibiting ERK2 phosphorylation;Cell Death & Disease;2023-03-25

5. Methylated ZNF582: a therapeutic target in oral cancer;Epigenomics;2022-11